They seem to acknowledge this:
The above graph is misleading in one way though because it is dependent on a specific metric, GDT_TS, which only measures gross topology. If we care about high resolution topology, which we certainly do for most practical applications, then a more appropriate metric is GDT_HA, and using it the picture looks a bit different:
[graph]
Still a good trendline, but much further down from a “solution”.
Another caveat is that both of these metrics measure global goodness of fit, which is important in terms of the basic scientific problem, but is often not indicative of functional utility. Local accuracy, for example the coordination of atoms in an active site or the localized change of conformation due to a mutation, is what is often sought when answering broader biological questions. Global metrics hide local discrepancy by diluting it in the sea of generally good agreement between experimental and predicted structures.
and
Even for MSA / family-level predictions, there is the question of desired accuracy, which hinges on the biological application. If one is predicting protein structures to ascertain their general fold for function classification, then high accuracy is unnecessary. If on the other hand the objective is to design small molecule drugs that bind proteins, which require ~1Å accuracy in the local pocket, it is unclear if we have made any detectable progress.
Cowsandmilks points out the limit of AlphaProtein above: https://news.ycombinator.com/item?id=18647187
The problem is one runs out of reasonably isolated problems with a reasonable metric.
I would have preferred that text in the comment you responded to had less of a trash talking feel to it.
Also it’s a bit overplayed because although these are special moments, there’s no shortage of examples in history where a new approach in one field is applied to get results previously unattainable in another.
However there’s no need for rationalizations. The result doesn’t generalize to anyone is smarter than anyone else, or that it’s not important because it’s not the super most important drug discovery tool.
It’s just a special moment where a technique is impacting another area of research. Which is part of a special period in history where AI/ML is evolving from being literally a joke that could defund your research, to finally having a broad set of useful applications.
We should be glad to see as many of these moments as possible from any discipline to any other.
It reminds me of the 90's and early 2000's when many were convinced that sequencing the human genome would suddenly make drug discovery a simple problem.
From my experience in research, pharma has found that cellular models and phenotypic assays are far more meaningful for pushing projects forward. So, there is far more interest in applying machine learning to that data than for building protein structures. And those same methods can be applied to target-based projects regardless of whether you have structure. And regardless of how flexible your protein is. Huge portions of structure-based modeling has no ability to deal with protein flexibility, even if you know there are open and closed conformations of the protein or a loop that adopts half a dozen configurations.
Basically, academics working on folding often believe far too much in the importance of structure in drug discovery. The author appears to fall into that category.